Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80462302 | 8046230 | 2 | F | 2011 | 20110706 | 20110720 | 20160902 | EXP | CA-UCBSA-034438 | UCB | 59.18 | YR | F | Y | 41.00000 | KG | 20160902 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80462302 | 8046230 | 1 | PS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 200 MG, EV 2 WEEKS(QOW) | Y | 58414 | 125160 | 200 | MG | SOLUTION FOR INJECTION | QOW | ||||
| 80462302 | 8046230 | 2 | SS | HYDROGEN PEROXIDE. | HYDROGEN PEROXIDE | 1 | U | 0 | |||||||||||
| 80462302 | 8046230 | 3 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | |||||||||||
| 80462302 | 8046230 | 4 | C | NIFEDIPINE. | NIFEDIPINE | 1 | 0 | ||||||||||||
| 80462302 | 8046230 | 5 | C | PREDNISONE. | PREDNISONE | 1 | Oral | MG | 0 | QD | |||||||||
| 80462302 | 8046230 | 6 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Oral | 200 MG, ONCE DAILY (QD) | 0 | 200 | MG | QD | |||||||
| 80462302 | 8046230 | 7 | C | RAMIPRIL. | RAMIPRIL | 1 | UNK | Y | 0 | ||||||||||
| 80462302 | 8046230 | 8 | C | ADVIL | IBUPROFEN | 1 | Oral | 0 | |||||||||||
| 80462302 | 8046230 | 9 | C | NYSTATIN. | NYSTATIN | 1 | Oral | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 80462302 | 8046230 | 1 | Rheumatoid arthritis |
| 80462302 | 8046230 | 2 | Dental disorder prophylaxis |
| 80462302 | 8046230 | 3 | Product used for unknown indication |
| 80462302 | 8046230 | 4 | Product used for unknown indication |
| 80462302 | 8046230 | 5 | Rheumatoid arthritis |
| 80462302 | 8046230 | 6 | Rheumatoid arthritis |
| 80462302 | 8046230 | 7 | Product used for unknown indication |
| 80462302 | 8046230 | 8 | Product used for unknown indication |
| 80462302 | 8046230 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 80462302 | 8046230 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 80462302 | 8046230 | Cheilitis | |
| 80462302 | 8046230 | Oral fungal infection | |
| 80462302 | 8046230 | Pruritus | |
| 80462302 | 8046230 | Rash | |
| 80462302 | 8046230 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 80462302 | 8046230 | 1 | 20100629 | 0 | ||
| 80462302 | 8046230 | 5 | 20091028 | 0 | ||
| 80462302 | 8046230 | 6 | 2008 | 0 |